MD Anderson and Myriad Genetics Join Forces to Assess Clinical Utility of Myriad’s Molecular Residual Disease Assay
The University of Texas MD Anderson Cancer Center has strategically aligned itself with Myriad Genetics, Inc. in a groundbreaking partnership ...